According to the information published by the Food and Drug Administration, Alprazolam, a generic Xanax drug from Mylan Pharmaceuticals, is being voluntarily recalled by the company. This recall has been issued as the maker has concerns over the ‘potential presence of a foreign substance’ in the drugs. A generic form of Xanax, this is one of the most popular and widely used drug across the United States. Attempts are being made to control the spread of the medicine and get the already-distributed packages from stores from many parts of the country.
“This lot is being recalled due to the potential presence of foreign substance. Clinical impact from the foreign material, if present, is expected to be rare, but the remote risk of infection to a patient cannot be ruled out. To date, Mylan has not received any adverse events related to this batch,” reads the official press release from Mylan Pharmaceuticals, as published on the official website of the FDA. Consumers are requested to contact Stericycle and follow the documented procedure if they have already purchased the drug from one of the retailers. It should be noted that the potentially contaminated packages were distributed between July and August of 2019.
“Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax,” adds the release when talking about the potential impacts of the drug in the future. It should be noted that Alprazolam is one of the widely used drugs when it comes to anxiety and panic disorder. On a single day, there are thousands of people who rely on the drug and such a recall makes serious issues for many of the users. Mylan has told that it has been looking into the reasons for the potential issue.